Novartis, Bill & Melinda Gates Foundation Collaborate On Vivo Gene Therapy For Sickle Cell Disease

(RTTNews) – Novartis AG (NVS) and the Bill & Melinda Gates Foundation have collaborated to discover and develop an accessible in vivo gene therapy for sickle cell disease, the Swiss multinational pharmaceutical company said in a statement.Novartis noted that the project bringRead MoreMarketsMarkets Feed

¡Haz clic para votar esta entrada!
(Votos: 0 Promedio: 0)

Deja un comentario